echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Npj Regen Med: Scientists may be developing new treatments for diabetes

    Npj Regen Med: Scientists may be developing new treatments for diabetes

    • Last Update: 2021-02-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    FEBRUARY 16, 2021 // -- In a recent study published in the international journal npj Regenerative Medicine, scientists from Monash University and others uncovered barriers to cell regeneration in β, and the results may help scientists develop new treatments for diabetes and related diseases such as organ and tissue damage.
    Photo Source: CC0 Public Domain The human body does not repair itself well, and the body's liver is the only organ that can be effectively regenerated, and the body's ability to regenerate new cells or tissues has become very limited since birth because genes involved in the body's development are turned off; To occur, DNA methylation is a biological process in which methylated groups are wrote on DNA and can modify the way genes function; this modification effectively silences the expression of progenitor cells (early offspring of stem cells) genes in the body, thereby reducing the pancreas's ability to produce insulin β cells.
    using mouse models, the researchers found that two key developmental genes, Ngn3 and Sox11, had reduced levels of DNA methylation, which may have prompted them to repair the dormant state of the cells.
    However, by de-methylation, progenitic cells can wake up again, restoring their ability to transform into new insulin-producing β cells, which may hopefully help develop improved treatments for type 1 and type 2 diabetes.
    researcher El-Osta said: 'By working together, we have uncovered some very interesting results, and we have found that DNA methylation may be a barrier to the regeneration of form β cells, which may help scientists restore the function of β cells in the pancreas.
    Currently, removing damage in the body of diabetics β cell populations consist mainly of complete pancreatic or islet transplants, which, while effective, also face organ donor shortages and side effects associated with immunosuppressive drugs.
    In this study, researchers focused on how to replace missing β cells in diabetic patients with multiple methods and cellular resources, but the key to developing the potential for these regeneration methods is to understand how tissue and cellular processes are controlled during development.
    , the researchers say, is a new, highly significant study that could help us treat diabetes by using stem cell-like cells to resusctic and transform them into insulin-producing cells.
    () Original source: Khurana, I., Al-Hasani, K., Maxwell, S. et al. DNA methylation status correlates with adult β-cell regeneration capacity. npj Regen Med 6, 7 (2021).doi:10.1038/s41536-021-00119-1
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.